JeanLGremMD

Clinical Trials

• Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma Start of enrollment: 1999 Jun 01

  Terminated

  Phase 1

• UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors Start of enrollment: 2002 Aug 01

  Completed

  Phase 1

• Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Start of enrollment: 2004 Feb 25

  Completed

  Phase 2

• Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Start of enrollment: 2005 Sep 08

  Completed

  Phase 2

• Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer Start of enrollment: 2004 Oct 01

  Completed

  Phase 1

• Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor Start of enrollment: 2007 Dec 01

  Active, not recruiting

  Phase 3

• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01

  Active, not recruiting

  Phase 3

• Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors Start of enrollment: 2010 Sep 14

  Completed

  Phase 1

• Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer Start of enrollment: 2011 Feb 28

  Terminated

  Phase 2

• ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer Start of enrollment: 2013 Apr 09

  Completed

  Phase 1

• FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer Start of enrollment: 2021 Feb 12

  Recruiting

  Phase 2

• Join now to see all